Home
News
Editorial
MD(e)B(unker)
Related Researches
Di Bella's Foundation
1960-1969
1970-1979
1980-1989
1990-1999
2000-2009
2010-2019
2020-2029
Science news
Scientific Documentation
About us...
Biography
Bibliography
The Method
Di Bella's Method!
1998 Trial!
Media
Video Publications
News-Papers
Press
Testimonial
Testimonies
Video Gallery
Congresses
Video Testimonies
TV & C.
Case History
Lung
Lymphomas
Non-Hodgkin Lymphomas
Hodgkin Lymphomas
Mediastinum
Mesothelioma
Myeloma
Pancreas
Scientific Publications
F.A.Q.
Useful Links
User Side
Vademecum
CouponChief - Resources for Cancer Patients
Contact Us
Home page
News
Related Researches
2000-2009
Title
Created Date
Melatonin modulates microfilament phenotypes in epithelial cells: implications for adhesion and inhibition of cancer cell migration
13 November 2013
Growth inhibition of experimental non-Hodgkin's lymphomas with the targeted cytotoxic somatostatin analogue AN-238
12 November 2013
Retinoic acid inhibits the proliferative response induced by CD40 activation and interleukin-4 in mantle cell lymphoma
11 November 2013
Growth hormone receptor is expressed in human breast cancer
11 November 2013
Role of vascular endothelial growth factor in regulation of physiological angiogenesis
10 November 2013
Retinoic acid dramatically enhances the arsenic trioxide-induced cell cycle arrest and apoptosis in retinoic acid receptor alpha-positive human T-cell lymphotropic virus type-I-transformed cells
10 November 2013
Therapy of ovarian cancers with targeted cytotoxic analogs of bombesin, somatostatin, and luteinizing hormone-releasing hormone and their combinations
08 November 2013
Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues
07 November 2013
Increased p21 expression and complex formation with cyclin E/CDK2 in retinoid-induced pre-B lymphoma cell apoptosis
06 November 2013
Somatostatin receptor subtype-dependent regulation of nitric oxide release: involvement of different intracellular pathways
06 November 2013
Display #
5
10
15
20
25
30
50
100
All
Page 97 of 111
Start
Prev
92
93
94
95
96
97
98
99
100
101
Next
End
Search
Follow us...
Latest
Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatonin
TARGETING TUMOR ASSOCIATED MACROPHAGES (TAMS) FOR CANCER TREATMENT: EXPLOITING MELATONIN AS BIOLOGICAL RESPONSE MODIFIER (BRM)
SSTR2-targeting therapy in EBV-positive and EBV-negative metastatic nasopharyngeal carcinoma
PROMISING COMPOUNDS WITH HEALTH BENEFITS: PHYTOMELATONIN AND MELATONIN
Understanding the role of melatonin in cancer metabolism
Melatonin: an essential factor for the treatment and recovery from leukemia and cancer
Radioprotective effects of melatonin on radiation-induced cataract
Radiomitigation by Melatonin in C57BL/6 Mice: Possible Implications as Adjuvant in Radiotherapy and Chemotherapy
Radiation-Induced Dual Oxidase Upregulation in Rat Heart Tissues: Protective Effect of Melatonin
Disease Control after Androgen Deprivation Therapy Combined with Di Bella Multitherapy
Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review
Radioprotective effect of melatonin on radiation-induced lung injury and lipid peroxidation in rats
Phenotypic changes caused by melatonin increased sensitivity of prostate cancer cells to cytokine-induced apoptosis
Oncostatic effects of the indole melatonin and expression of its cytosolic and nuclear receptors in cultured human melanoma cell lines
Targeting Growth Hormone Receptor to Overcome Therapy Resistance in Non-Small Cell Lung Cancer
Dopamine D2 Receptor Agonists as Modulators of VEGF-A-Driven Angiogenesis: Mechanisms, Clinical Evidence, and Translational Opportunities
[68Ga]Ga-DOTA-TOC positron emission tomography outperforms [18F]FDOPA and [18F]FDG PET in pediatric neuroblastoma imaging: a prospective study
Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis
Most Read
The Di Bella Method (DBM)
About melatonin - 1996
All-trans-retinoic acid and cancer
Biography
Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
Somatostatin in oncology, the overlooked evidences
The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
Bibliography
Complete objective response to biological therapy of plurifocal breast carcinoma
How effective is chemo therapy?
Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
Vademecum
Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
Frequently Asked Questions
Declaration recommends eliminate the use of Impact factor for research evaluation
Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer